Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>C9orf72</i> poly(glycine-alanine) knock-in mice exhibit mild rotarod and proteomic changes consistent with amyotrophic lateral sclerosis/frontotemporal dementia.

Brain communications·2026
Same author

Why we need to depict the structure of DNA correctly: it's so groovy.

Brain : a journal of neurology·2026
Same author

Impaired BDNF-TrkB trafficking and signalling in Down syndrome basal forebrain neurons.

Cell death & disease·2026
Same author

Generation of <i>C9orf72</i> repeat knock-in iPSC lines for modelling ALS and FTD.

bioRxiv : the preprint server for biology·2025
Same author

Challenges of modelling TDP-43 pathology in mice.

Mammalian genome : official journal of the International Mammalian Genome Society·2025
Same author

Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437].

Neurobiology of disease·2024

Related Experiment Video

Updated: Mar 30, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.6K

Dissecting Alzheimer disease in Down syndrome using mouse models.

Xun Yu Choong1, Justin L Tosh1, Laura J Pulford1

  • 1Department of Neurodegenerative Disease, Institute of Neurology, University College London London, UK ; The LonDownS Consortium London, UK.

Frontiers in Behavioral Neuroscience
|November 4, 2015
PubMed
Summary

Down syndrome (DS), caused by trisomy 21, significantly elevates Alzheimer's disease (AD) risk. Mouse models help study AD in DS (AD-DS) to understand dementia mechanisms relevant to all populations.

Keywords:
APPAlzheimer diseaseDown syndromemouse modelstrisomy 21

More Related Videos

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-&#946; and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

28.4K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.2K

Related Experiment Videos

Last Updated: Mar 30, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.6K
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-&#946; and Tau Neuropathology
10:02

Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology

Published on: May 28, 2017

28.4K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

4.2K

Area of Science:

  • Genetics
  • Neuroscience
  • Pathology

Background:

  • Down syndrome (DS) is a genetic condition resulting from trisomy 21.
  • Individuals with DS have a significantly higher risk of developing Alzheimer's disease (AD) neuropathology.
  • Not all individuals with DS who exhibit AD neuropathology develop dementia.

Purpose of the Study:

  • To dissect the genetic contribution of trisomy 21 to Down syndrome phenotypes, particularly those relevant to Alzheimer's disease.
  • To review the characteristics of Alzheimer's disease in Down syndrome (AD-DS).
  • To identify essential features for future DS-AD mouse models.

Main Methods:

  • Generation of Down syndrome mouse models trisomic for chromosome segments syntenic to human chromosome 21.
  • Review of existing knowledge on AD and DS mouse models.
  • Analysis of key characteristics of human AD in DS.

Main Results:

  • DS mouse models provide insights into trisomy 21's genetic contribution to AD-related phenotypes.
  • Understanding AD-DS requires comprehensive analysis of neuropathology and dementia development.
  • Current models offer a foundation for future research into AD pathogenesis in DS.

Conclusions:

  • DS mouse models are crucial for dissecting the genetic basis of AD-DS.
  • Future models must accurately recapitulate AD-DS phenotypes to advance understanding.
  • Research on AD-DS can illuminate pathogenic mechanisms relevant to sporadic AD in the general population.